Ovarian reserve is a complex clinical phenomenon influenced by age, genetics, and
environmental variables. Although it is challenging to predict the rate of an individual's …

BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been
applied to a wide array of clinical applications, mainly based on its ability to reflect the …

Background Anti-Müllerian hormone (AMH) is a product of growing ovarian follicles. The
concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, ie …

BACKGROUND Stratified (individualized) medicine has been recognized as a key priority
for policy makers and healthcare providers. The main principle of individualized care …

Context: Existing biochemical tests for polycystic ovary syndrome (PCOS) have poor
sensitivity and specificity. Many women with PCOS have high anti-Müllerian hormone (AMH) …

Context: Anti-Müllerian hormone (AMH) is an accurate marker of ovarian reserve. However,
sufficiently large sets of normative data from infancy to the end of reproductive life are …

There are large variations in the number of oocytes within each woman, and biologically, the
total quantity is at its maximum before the woman is born. Scientific knowledge is limited …

With our increasing appreciation that simply maximizing oocyte yield for all patients is no
longer an appropriate stimulation strategy and that age alone cannot accurately predict …

Polycystic ovary syndrome (PCOS), the most common endocrine disorder among women of
reproductive age, is characterized by the coexistence of hyperandrogenism, ovulatory …